|105.51||+2.20 / +2.13%|
As of 3:59pm ET
|104.18||-1.33 / -1.26%|
The 5 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 147.00, with a high estimate of 151.00 and a low estimate of 135.00. The median estimate represents a +39.32% increase from the last price of 105.51.
The current consensus among 5 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.